Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited has announced a special dividend of RMB 0.12 per share for the financial year ending 31 December 2024, with payment to be made in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.094945. This announcement reflects the company’s strong financial performance and commitment to providing value to its shareholders, with the payment date set for 23 July 2025.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its commitment to quality and innovation in the healthcare sector.
YTD Price Performance: 20.23%
Average Trading Volume: 13,263,745
Technical Sentiment Signal: Buy
Current Market Cap: HK$27B
See more insights into 3933 stock on TipRanks’ Stock Analysis page.